Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Forhecz Topher and Financial Times. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Forhecz Topher and Financial Times or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

How Ireland became the weak spot in Europe’s defences

10:26
 
Share
 

Manage episode 521115366 series 2455123
Content provided by Forhecz Topher and Financial Times. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Forhecz Topher and Financial Times or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Traders are piling into bets that Wednesday’s UK Budget will push the pound lower against the dollar, and the pharmaceutical industry saw some promising — and not so promising — clinical trial results. Plus, US tech stocks leapt on Monday and Ireland’s military neutrality has created a weak spot in Europe’s defences.


Mentioned in this podcast:

Currency traders bet against sterling ahead of Budget

Novo Nordisk shares slump after drug failure in Alzheimer’s trial

Bayer soars on promising trial results for stroke prevention drug

US tech stocks surge as Fed rate cut bets fuel rebound

How Ireland became the weak spot in Europe’s defences


Note: The FT does not use generative AI to voice its podcasts


Today’s FT News Briefing was hosted and edited by Marc Filippino, and produced by Fiona Symon, and Sonja Hutson. Our show was mixed by Kelly Garry. Additional help from Gavin Kallmann, Michael Lello and David da Silva. The FT’s acting co-head of audio is Topher Forhecz. The show’s theme music is by Metaphor Music.


Read a transcript of this episode on FT.com


Hosted on Acast. See acast.com/privacy for more information.

  continue reading

2000 episodes

Artwork
iconShare
 
Manage episode 521115366 series 2455123
Content provided by Forhecz Topher and Financial Times. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Forhecz Topher and Financial Times or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Traders are piling into bets that Wednesday’s UK Budget will push the pound lower against the dollar, and the pharmaceutical industry saw some promising — and not so promising — clinical trial results. Plus, US tech stocks leapt on Monday and Ireland’s military neutrality has created a weak spot in Europe’s defences.


Mentioned in this podcast:

Currency traders bet against sterling ahead of Budget

Novo Nordisk shares slump after drug failure in Alzheimer’s trial

Bayer soars on promising trial results for stroke prevention drug

US tech stocks surge as Fed rate cut bets fuel rebound

How Ireland became the weak spot in Europe’s defences


Note: The FT does not use generative AI to voice its podcasts


Today’s FT News Briefing was hosted and edited by Marc Filippino, and produced by Fiona Symon, and Sonja Hutson. Our show was mixed by Kelly Garry. Additional help from Gavin Kallmann, Michael Lello and David da Silva. The FT’s acting co-head of audio is Topher Forhecz. The show’s theme music is by Metaphor Music.


Read a transcript of this episode on FT.com


Hosted on Acast. See acast.com/privacy for more information.

  continue reading

2000 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play